FDA clearances and approvals, off-label use, scope-of-practice rules, and how to read a 510(k) summary without trusting the marketing wrapper.
An evidence-first guide on medical tourism for cosmetic surgery, analyzing CDC mortality/infection data, high-risk procedure combinations, and safety vetting.
An evidence-first comparison of FDA-approved Latisse (bimatoprost) and OTC eyelash growth serums, detailing prostaglandin eye risks, class actions, and efficacy.
An evidence-based decision guide comparing FUE, FUT, and DHI hair transplant techniques, detailing real graft survival rates, ischemia times, contraindications, and…
An evidence-first global regulatory and corporate analysis of BTL Aesthetics. We examine registry records across 15+ countries, its direct-subsidiary structure, and…
A comprehensive global regulatory and corporate analysis of Lumenis. We explore the $1.07B Boston Scientific acquisition split, global registry profiles, recall history,…
A clinical guide to breast implant removal surgery — comparing en bloc, total, and partial capsulectomy, the 2024 consensus on breast implant illness, recovery, and cost.
How the European Union Medical Device Regulation regulates aesthetic lasers, fillers, and implants, the 2026 EUDAMED mandatory deadlines, and how a CE mark compares to…
How the federal Sunshine Act and California AB 1278 expose manufacturer payments to dermatologists and plastic surgeons, how patients look up doctors, and what practices…
Are skin boosters FDA-approved? We analyze the US regulatory status of Skinvive, Profhilo, NCTF, Restylane Skinbooster, and how the FDA detains unapproved imports.
BTL Aesthetics is the force behind Emsculpt Neo, Emface, and Emsella. We analyze their complete FDA 510(k) clearances, indications, safety record, and the regulatory…